Grant RadarWorldwide funding
Log inGet started
Back to Grants
Health Open for ApplicationsRFA-HL-26-002

NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)

National Institutes of Health opportunity RFA-HL-26-002

Eligible Applicants
Organization Types
UniversitiesNGOsSMEsGovernment Agencies
Eligible Countries / Regions
United States
Keywords
National Institutes of HealthRFA-HL-26-002Grants.gov
Related Grants
Health● Open
Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)
Varies
07 Jan 2028(462d)
Health● Open
Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
Varies
21 Aug 2028(689d)
HealthUpcoming
Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not
Varies
HealthUpcoming
Dental Primary Care Practice-Based Research Network: Clinical Trial or Observational Study Planning and Implementation Cooperative Agreement
Varies
Funding Amount
Varies
USD
Application Deadline
28 April 2027
208 days remaining
Opens: 26 Apr 2024
Apply Now
Programme Details
Programme Code
RFA-HL-26-002